Mari Kamiya

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Disease Activity

Rheumatoid Arthritis Patients

Top Venues

Rheumatology advances in practice

Rheumatology (Oxford, England)

Journal of cachexia, sarcopenia and muscle

This page only lists publications with an associated author ORCID identifier.

Publications

Takumi Matsumoto, Takahiko Sugihara, Tadashi Hosoya, Tatsuro Ishizaki, Kanae Kubo, Mari Kamiya, Hiroyuki Baba, Marina Tsuchida, Fumio Hirano, Masayo Kojima, Nobuyuki Miyasaka, Masayoshi Harigai
Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients >75 years of age. Rheumatology advances in practice 8 (1) (2024)
Takumi Matsumoto, Takahiko Sugihara, Tadashi Hosoya, Tatsuro Ishizaki, Kanae Kubo, Mari Kamiya, Hiroyuki Baba, Marina Tsuchida, Fumio Hirano, Masayo Kojima, Nobuyuki Miyasaka, Masayoshi Harigai
Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients >75 years of age. Rheumatology advances in practice 8 (1) (2024)
Riku Yoshizuka, Hisanori Hasegawa, Mari Kamiya, Natsuka Umezawa, Shinsuke Yasuda
Refractory antiphospholipid antibody syndrome-induced thrombocytopaenia successfully treated with belimumab. Lupus 31 (5) (2022)
Mari Kamiya, Fumitaka Mizoguchi, Shinsuke Yasuda
Amelioration of inflammatory myopathies by glucagon-like peptide-1 receptor agonist via suppressing muscle fibre necroptosis. Journal of cachexia, sarcopenia and muscle 13 (4) (2022)
Takahiko Sugihara, Tatsuro Ishizaki, Wataru Onoguchi, Hiroyuki Baba, Takumi Matsumoto, Shoko Iga, Kanae Kubo, Mari Kamiya, Fumio Hirano, Tadashi Hosoya, Nobuyuki Miyasaka, Masayoshi Harigai
Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study. Rheumatology (Oxford, England) 60 (9) (2021)